" Tungsten demand surges with nuclear fusion growth "
https://in.investing.com/news/company-news/tungsten-demand-surges-with-nuclear-fusion-growth-93CH-4703027
Here is another article on that subject from the financial press - no doubt we will be seeing a few more of these over the coming days
All the big players in the fusion space will no doubt be scrambling for a guarantee of supply in order to build their fusion chambers - its a ways off yet but we need to understand 3 key points here
Firstly, this is a relatively new use of tungsten. The fusion industry has been a consumer of tungsten recently but basically only for testing in the fusion chambers to confirm that it would perform the best of any material. Many subsequent tests have conclusively proven that tungsten, due mainly to its high heat tolerance, was the best material for the job. As we already know, tungsten has been used extensively as carbides in drill equipment for mining, engineering, manufacturing, aviation, aerospace and automotive industries. But its use in the nuclear fusion process will be very new indeed and consequently will likely have a big impact on the demand curve. (Summary: Its a new use)
Secondly, the sheer quantity of tungsten required, as evidenced in this paper, is absolutely HUGE. Western world demand as we know is already going to face a big struggle to be met by western suppliers, of which there are very few. Add to this the additional pressure of trying to accommodate a massive increase will put this most critical of critical metals in very very high demand. (Summary: its huge volume)
Finally - the time frames mentioned in the paper, might seem a long way off, but bear in mind that these nuclear chambers will take many years to build so the demand for tungsten will be slow, progressive and constantly on the up and up. (Summary: Its use will not be as far off as you think)
- Forums
- ASX - By Stock
- EQR
- Ann: Quarterly Activities/Appendix 5B Cash Flow Report
EQR
eq resources limited
Add to My Watchlist
10.8%
!
4.1¢

Ann: Quarterly Activities/Appendix 5B Cash Flow Report, page-207
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
4.1¢ |
Change
0.004(10.8%) |
Mkt cap ! $111.8M |
Open | High | Low | Value | Volume |
4.0¢ | 4.2¢ | 3.7¢ | $306.8K | 7.833M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 78945 | 3.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.1¢ | 349999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 78945 | 0.038 |
1 | 4000 | 0.037 |
1 | 75000 | 0.035 |
3 | 165000 | 0.034 |
3 | 369581 | 0.033 |
Price($) | Vol. | No. |
---|---|---|
0.041 | 349999 | 1 |
0.043 | 88255 | 2 |
0.044 | 575714 | 3 |
0.045 | 1268034 | 2 |
0.046 | 370000 | 2 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
EQR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online